The underlying mechanisms of the seemingly paradoxical finding that CB1 agonists, similar to CB1 inverse agonists, promote weight loss and protect against obesity have not been fully elucidated. This evidence concerns the gene CNR1 and obesity due to melanocortin 4 receptor deficiency.